本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Sutro Biopharma Inc

9.83
+0.02000.20%
盤後9.61-0.2200-2.24%16:45 EST
成交量:12.16萬
成交額:119.48萬
市值:8,374.56萬
市盈率:-0.38
高:10.10
開:9.78
低:9.53
收:9.81
52周最高:24.80
52周最低:5.23
股本:851.94萬
流通股本:610.25萬
量比:1.06
換手率:1.99%
股息:- -
股息率:- -
每股收益(TTM):-25.8759
每股收益(LYR):-29.6061
淨資產收益率:-1810.01%
總資產收益率:-25.80%
市淨率:-0.96
市盈率(LYR):-0.33

資料載入中...

2024/11/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

重要事件披露

Form 8-K - Current report
2024/11/12

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/04

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/08/13

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/13

重要事件披露

Form 8-K - Current report
2024/08/12

重要事件披露

Form 8-K - Current report
2024/06/10

重要事件披露

Form 8-K - Current report
2024/05/13

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/13

重要事件披露

Form 8-K - Current report
2024/04/05

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/04/02

重要事件披露

Form 8-K - Current report
2024/04/02

重要事件披露

Form 8-K - Current report
2024/03/25

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/03/25

重要事件披露

Form 8-K - Current report
2024/02/27

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/02/13

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/12

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/09

重要事件披露

Form 8-K - Current report
2024/02/07

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]